Neuroprotective effects of the antioxidant action of 2-cyclopropylimino-3-methyl-1,3-thiazoline hydrochloride against ischemic neuronal damage in the brain
2
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Ischemia is characterized by oxidative stress and changes in the antioxidant defense system. Our recent in vitro study showed that 2-cyclopropylimino-3-methyl-1,3-thiazoline hydrochloride protects cortical astrocytes against oxidative stress. In the current study, we examined the effects of 2-cyclopropylimino-3-methyl-1,3-thiazoline hydrochloride on ischemia-induced neuronal damage in a gerbil ischemia/reperfusion models. Extensive neuronal death in the hippocampal CA1 area was observed 4 days after ischemia/reperfusion. Intraperitoneal injection of 2-cyclopropylimino-3-methyl-1,3-thiazoline hydrochloride (0.3 mg/kg body weight) significantly prevented neuronal death in the CA1region of the hippocampus in response to transient forebrain ischemia. 2-Cyclopropylimino-3-methyl-1,3-thiazoline hydrochloride administration reduced ischemia-induced increases in reactive oxygen species levels and malondialdehyde content. It also attenuated the associated reductions in glutathione level and superoxide dismutase, catalase, and glutathione peroxidase activities. Taken together, our results suggest that 2-cyclopropylimino-3-methyl-1,3-thiazoline hydrochloride protects against ischemia-induced neuronal damage by reducing oxidative stress through its antioxidant actions.
Abstract
Ischemia is characterized by oxidative stress and changes in the antioxidant defense system. Our recent in vitro study showed that 2-cyclopropylimino-3-methyl-1,3-thiazoline hydrochloride protects cortical astrocytes against oxidative stress. In the current study, we examined the effects of 2-cyclopropylimino-3-methyl-1,3-thiazoline hydrochloride on ischemia-induced neuronal damage in a gerbil ischemia/reperfusion models. Extensive neuronal death in the hippocampal CA1 area was observed 4 days after ischemia/reperfusion. Intraperitoneal injection of 2-cyclopropylimino-3-methyl-1,3-thiazoline hydrochloride (0.3 mg/kg body weight) significantly prevented neuronal death in the CA1region of the hippocampus in response to transient forebrain ischemia. 2-Cyclopropylimino-3-methyl-1,3-thiazoline hydrochloride administration reduced ischemia-induced increases in reactive oxygen species levels and malondialdehyde content. It also attenuated the associated reductions in glutathione level and superoxide dismutase, catalase, and glutathione peroxidase activities. Taken together, our results suggest that 2-cyclopropylimino-3-methyl-1,3-thiazoline hydrochloride protects against ischemia-induced neuronal damage by reducing oxidative stress through its antioxidant actions.
참고문헌 (39)
- Oostveen, J. A., "Neuroprotective efficacy and mechanisms of novel pyrrolopyrimidine lipid peroxidation inhibitors in the gerbil forebrain ischemia model", J. Cereb. Blood Flow Metab, 18, pp.539~547 (1998)
- Floyd, R. A., "Role of oxygen free radicals in carcinogenesis and brain ischemia", FASEB J, 4, pp.2587~2597 (1990)
- Petito, C. K., "DNA fragmentation follows delayed neuronal death in CA1 neurons exposed to transient global ischemia in the rat", J. Cereb. Blood Flow. Metab, 17, pp.967~976 (1997)
- Frantseva, M. V., "Dynamics of intracellular calcium and free radical production during ischemia in pyramidal neurons", Free Radic. Biol. Med, 31, pp.1216~1227 (2001)
- Li, P. S., "Free radical spin trap α-phenyl-N-tertbutyl-nitron inhibits caspase-3 activation and reduces brain damage following a severe forebrain ischemic injury. Free Radic. Biol. Med", Free Radic. Biol. Med, 31, pp.1191~1197 (2001)
- Dore, S., "Neuronal overexpression of cyclooxygenase-2 increases cerebral infarction", Ann. Neurol, 5, pp.155~162 (2003)
- Sayre, L. M., "Oxidative stress and neurotoxicity", Chem. Res. Toxicol, 21, pp.172~188 (2008)
- Fallarini, S., "Clovamide and rosmarinic acid induce neuroprotective effects in vitro models of neuronal death", Br. J. Pharmacol, 15, pp.1072~1084 (2009)
- Beal, M. F., "Do defects in mitochondrial energy metabolism underlie the pathology of neurodegenerative diseases?", Trends Neurosci, 16, pp.125~131 (1993)
- Trushina, E., "Oxidative stress and mitochondrial dysfunction in neurodegenerative diseases", Neuroscience, 145, pp.1233~1248 (2007)
- Margaill, I., "Antioxidant strategies in the treatment of stroke", Free Radic. Biol. Med, 39, pp.429~443 (2005)
- Schreibelt, G., "Therapeutic potential and biological role of endogenous antioxidant enzymes in multiple sclerosis pathology", Brain Res. Rev, 56, pp.322~330 (2007)
- Choi, M. M., "Protective effect of benzothiazole derivative KHG21834 on amyloid beta-induced neurotoxicity in PC12 cells and cortical and mesencephalic neurons", Toxicology, 239, pp.156~166 (1834)
- Kim, E. A., "Suppression of glutamate-induced excitotoxicity by 2-cyclopropylimino-3-methyl-1,3-thiazoline hydrochloride in rat glial cultures", Cell. Mol. Neurobiol, 30, pp.807~815 (2010)
- Eun-A Kim, "Attenuation of β-amyloid-induced neuroinflammation by KHG21834 in vivo", BMB Reports, 43(6), pp.413~418 (2010), 생화학분자생물학회
- Kim, H., "Neuroprotective effects of 2-cyclopropylimino-3-methyl-1,3-thiazoline hydrochloride against oxidative stress", Cell. Mol. Neurobiol, 31, pp.979~984 (2011)
- Urbani, A., "Riluzole inhibits the persistent sodium current in mammalian CNS neurons", Eur. J. Neurosci, 12, pp.3567~3574 (2000)
- Heiser, V., "Identification of benzothiazoles as potential polyglutamine aggregation inhibitors of Huntington's disease by using an automated filter retardation assay", Proc. Natl. Acad. Sci. U.S.A, 99, pp.16400~16406 (2002)
- Ishiyama, T., "Riluzole slows the progression of neuromuscular dysfunction in the wobbler mouse motor neuron disease", Brain Res, 1019, pp.226~236 (2004)
- Brantley, E., "Anti-tumor drug candidate 2-(4-amino-3-methyl phenyl)-5-fluorobenzothiazole induces single-strand breaks and DNA-protein cross-links in sensitive MCF-7 breast cancer cells", Cancer Chemother. Pharmacol, 58, pp.62~72 (2006)
- Mortimer, C. G., "Antitumor Benzothiazoles. 26.1 2-(3,4-Dimethoxyphenyl)- 5-fluorobenzothiazole (GW 610, NSC 721648), a simple fluorinated 2-arylbenzothiazole, shows potent and selective inhibitory activity against lung, colon, and breast cancer cell lines", J. Med. Chem, 49, pp.179~185
- Pietrancosta, N., "Imino-tetrahydro-benzothiazole derivatives as p53 inhibitors : discovery of a highly potent in vivo inhibitor and its action mechanism", J. Med. Chem, 49, pp.3645~3652 (2006)
- -4 pyrimidinyl) acetonitrile): a c-Jun NH2-terminal protein kinase inhibitor with neuroprotective properties, "J. Pharmacol. Exp. Ther", 2004, 25~32
- Small, D. L., "Animal models", Br. Med. Bull, 56, pp.307~317 (2000)
- McKracken, E., "4-Hydroxynonenal immunoreactivity is increased in human hippocampus after global ischemia", Brain Pathol, 11, pp.414~421 (2001)
- Kim, D. W., "Transduced human PEP-1-catalase fusion protein attenuates ischemic neuronal damage", Free Radic. Biol. Med, 47, pp.941~952 (2009)
- Dae Won Kim, "Imipramine enhances neuroprotective effect of PEP-1-Catalase against ischemic neuronal damage", BMB Reports, 44(10), pp.647~652 (2011), 생화학분자생물학회
- Chan, P. H., "Role of oxidants in ischemic brain damage", Stroke, 27, pp.1124~1129 (1996)
- Piantadosi, C. A., "Mitochondrial generation of reactive oxygen species after brain ischemia in the rat", Stroke, 27, pp.327~331 (1996)
- Liu, D., "Astrocytic demise precedes delayed neuronal death in focal ischemic rat brain", Mol. Brain Res, 68, pp.29~41 (1999)
- Vieira, H. L., "The adenine nucleotide translocator: a target of nitric oxide, peroxynitrite, and 4-hydroxynonenal", Oncogene, 20, pp.4305~4316 (2001)
- Candelario-Jalil, E., "Time course of oxidative damage in different brain regions following transient cerebral ischemia in gerbils", Neurosci. Res, 41, pp.233~241 (2001)
- Wang, Q., "Neuroprotective mechanisms of curcumin against cerebral ischemia-induced neuronal apoptosis and behavioral deficits", J. Neurosci. Res, 82, pp.138~148 (2005)
- Sharma, S. S., "FeTPPS protects against global cerebral ischemic-reperfusion injury in gerbils", Pharmacol. Res, 55, pp.335~342 (2007)
- Dringen, R., "Metabolism and functions of glutathione in brain", Prog. Neurobiol, 62, pp.649~671 (2000)
- Schulz, J. B., "Glutathione, oxidative stress and neurodegeneration", Eur. J. Biochem, 267, pp.4904~4911 (2000)
- Lombardi, G., "Cabergoline prevents necrotic neuronal death in an in vitro model of oxidative stress", Eur. J. Pharmacol, 457, pp.95~99 (2002)
- Flohe, L, "Assay of glutathione peroxidase", Methods Enzymol, 105, pp.114~121 (1984)
- Aebi, H., "Catalase in vitro", Methods Enzymol, 105, pp.121~126 (1984)
